Sai Life Sciences Powers Bidar Campus with 100% Renewable Energy

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Sai Life Sciences Powers Bidar Campus with 100% Renewable Energy
Overview

Sai Life Sciences' Bidar campus is now powered entirely by renewable electricity, making it the first Indian CRDMO site to achieve this. The company avoids an estimated 35,110 metric tonnes of CO2 emissions annually, using solar, wind power, and renewable energy certificates. This enhances its sustainability profile.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Sai Life Sciences Powers Bidar Campus with 100% Green Energy

Sai Life Sciences has officially transitioned its Bidar campus to run entirely on renewable electricity. This achievement marks a significant step, making it the first Indian Contract Research, Development & Manufacturing Organization (CRDMO) site to achieve such a status. The transition involved a phased approach utilizing solar power, wind energy, and renewable energy certificates.

Boosting Sustainability and Client Appeal

This milestone significantly enhances Sai Life Sciences' Environmental, Social, and Governance (ESG) profile. In the competitive CRDMO sector, strong sustainability credentials are increasingly vital for attracting global clients and meeting evolving regulatory demands. The company's commitment to responsible operations is now clearly demonstrated beyond its core manufacturing activities.

The Journey to 100% Renewables

The Bidar campus, a key site for API and animal health API manufacturing, has seen a progressive adoption of renewable energy sources over the past few years. Renewable electricity usage climbed from 21% in fiscal year 2020 to 89% in fiscal year 2024. Currently, approximately 97% of the energy comes from direct solar and wind power. This initiative aligns with the company's broader organizational goal to source around 80% of its total electricity from renewables.

Impacts of the Green Shift

The shift to fully renewable energy brings several key benefits. It enhances Sai Life Sciences' appeal to environmentally conscious global clients and potentially reduces operational risks tied to carbon emissions and energy price volatility. Crucially, the Bidar campus now operates with zero market-based emissions from purchased electricity, a key environmental metric. This demonstrates the successful integration of renewable energy solutions into its manufacturing operations.

Industry Peers on Sustainability

Other major Indian CRDMOs are also focusing on sustainability. Syngene International is investing in similar initiatives and renewable energy to lower its carbon footprint. Laurus Labs has been actively adopting solar power across its manufacturing sites to reduce energy costs and emissions. Divi's Laboratories, another large API manufacturer, emphasizes environmental compliance and has plans for energy efficiency improvements.

Key Figures and Future Outlook

The Bidar campus's renewable energy usage saw significant growth: 21% in FY20, 57% in FY22, and 89% in FY24. The transition helps avoid approximately 35,110 metric tonnes of CO2 emissions annually, supported by a 2.7 MW installed wind project capacity. Sai Life Sciences will continue working towards its fiscal 2026 target for 100% renewable power conversion at the Bidar campus. Investors will watch for evidence of how these sustainability initiatives are integrated into the company's overall business growth and client acquisition strategies, as well as potential expansion to other facilities and disclosure of Scope 1 and Scope 3 emission reduction targets.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.